1. Home
  2. TREX vs CORT Comparison

TREX vs CORT Comparison

Compare TREX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TREX
  • CORT
  • Stock Information
  • Founded
  • TREX 1996
  • CORT 1998
  • Country
  • TREX United States
  • CORT United States
  • Employees
  • TREX N/A
  • CORT N/A
  • Industry
  • TREX
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TREX
  • CORT Health Care
  • Exchange
  • TREX Nasdaq
  • CORT Nasdaq
  • Market Cap
  • TREX 6.9B
  • CORT 7.6B
  • IPO Year
  • TREX 1999
  • CORT N/A
  • Fundamental
  • Price
  • TREX $64.70
  • CORT $70.33
  • Analyst Decision
  • TREX Buy
  • CORT Strong Buy
  • Analyst Count
  • TREX 14
  • CORT 4
  • Target Price
  • TREX $71.93
  • CORT $138.25
  • AVG Volume (30 Days)
  • TREX 1.8M
  • CORT 863.6K
  • Earning Date
  • TREX 08-04-2025
  • CORT 07-31-2025
  • Dividend Yield
  • TREX N/A
  • CORT N/A
  • EPS Growth
  • TREX N/A
  • CORT N/A
  • EPS
  • TREX 1.73
  • CORT 1.11
  • Revenue
  • TREX $1,129,138,000.00
  • CORT $716,080,000.00
  • Revenue This Year
  • TREX $8.47
  • CORT $35.85
  • Revenue Next Year
  • TREX $7.69
  • CORT $35.22
  • P/E Ratio
  • TREX $37.33
  • CORT $63.10
  • Revenue Growth
  • TREX N/A
  • CORT 25.71
  • 52 Week Low
  • TREX $49.01
  • CORT $33.34
  • 52 Week High
  • TREX $80.74
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • TREX 54.67
  • CORT 47.40
  • Support Level
  • TREX $60.29
  • CORT $70.05
  • Resistance Level
  • TREX $65.16
  • CORT $71.28
  • Average True Range (ATR)
  • TREX 2.68
  • CORT 1.75
  • MACD
  • TREX -0.16
  • CORT -0.08
  • Stochastic Oscillator
  • TREX 80.52
  • CORT 19.64

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: